Let's Talk Blood Cancer, The Patients' Podcast

"We Were An Hour From Going Bust"

On this episode of Let’s Talk Blood Cancer, The Patients’ Podcast, we are joined by James McLaughlin, Chief Executive of Cure Leukaemia. What’s in this episode: * James’ route into Cure Leukaemia, from his career in sport with organisations including Nike, Watford FC and Edgbaston Cricket Club * How meeting Cure Leukaemia co-founders Professor Charlie Craddock and Graham Silk inspired him to join the charity’s mission * Why his commercial and marketing background has helped drive the charity’s growth and fundraising success * The importance of keeping patients at the heart of every decision and seeing first-hand the impact of clinical research * The partnerships and fundraising milestones that helped transform Cure Leukaemia * The story behind Tour 21 and the moment Cure Leukaemia came within “an hour of going bust” * James’ vision for the future, including expanding access to clinical trials and growing the ATICUS Network to improve treatment options for children with blood cancer Find out more about Cure Leukaemia and how you can get involved and support blood cancer patients across the globe: ⁠⁠⁠https://www.cureleukaemia.co.uk/⁠ [⁠⁠⁠https://www.cureleukaemia.co.uk/⁠]

How Clinical Trials Are Changing Lives

On this special International Clinical Trials Day episode of Let’s Talk Blood Cancer, The Patients’ Podcast, we are joined by Professor Chris Fox, Professor of Haematology at Nottingham University Hospitals and Medical Director of the Trials Acceleration Programme (TAP), to discuss the vital role clinical trials play in advancing blood cancer treatment and improving patient outcomes. What’s in this episode: * Professor Fox’s journey into haematology and lymphoma, and the differences between lymphoma and leukaemia * How he balances patient care with leading and designing clinical trials to bring new treatments to patients * Why clinical trials are essential for developing safer and more effective therapies for blood cancers * The major advances transforming lymphoma treatment, including immunotherapy, CAR-T cell therapy, and bispecific antibodies * The impact of the Trials Acceleration Programme (TAP) in improving access to pioneering clinical trials across the UK * Why Professor Fox believes the future of lymphoma treatment is incredibly promising, with continued progress expected over the next decade Find out more about Cure Leukaemia and how you can get involved and support blood cancer patients across the globe: ⁠⁠https://www.cureleukaemia.co.uk/⁠ [https://www.youtube.com/redirect?event=video_description&redir_token=QUFFLUhqazNPOE5fdnFsX2cxZnQ2bV9lWndKcWkyYTBTUXxBQ3Jtc0ttSEwydUZWZUw1UUZnTmQtQ0gxN1QzVFk4dmhNVGM1UmoxZGF3dXpPLTVaQVQ0ZGkzbmU4UGV0dHZ0QlRyNzM5Y0NMZnZlRGJqSC1IUTNKSElVZUtWMUNyNjNObmlJYUhlT0pRdGFFX1JWRXpjN0lLUQ&q=https%3A%2F%2Fwww.cureleukaemia.co.uk%2F%E2%81%A0&v=tYOjTMsixUs]

"Today's Research Is Tomorrows Standard Of Care"

In this special International Nurses Day episode of Let’s Talk Blood Cancer, The Patients' Podcast, host Adam Joyce is joined by Jesusa (Jes) Sulit, Sian Fowdur, and Abi Sutcliffe — three Clinical Research Nurses from Nottingham University Haematology Ward — to explore the vital role research nurses play in blood cancer clinical trials and patient care. What’s in this episode: - What a Clinical Research Nurse does- Supporting patients through long-term clinical trials from consent to treatment and beyond - Why research nurses are often described as “navigators” for patients throughout their cancer journey - How clinical trials help turn today’s research into tomorrow’s standard of care - The impact research has had on blood cancer treatment, including less toxic therapies and home-based treatments - Why research nurses are essential to running safe and effective clinical trials - Addressing misconceptions and fears patients may have about joining clinical trials - The emotional highs and lows of supporting patients through treatment and remission - Why the role is so rewarding and the lasting difference research nurses can make to patient outcomes - Reflections on International Nurses Day and the future of blood cancer care Thank you to all Clinical Research Nurses for the incredible work they do to improve outcomes for blood cancer patients around the world.

Understanding AML with an Expert

In this episode, we’re joined by Professor Steve Knapper a Consultant Haematologist Hospital at Wales. Find out more about Cure Leukaemia and how you can get involved and support blood cancer patients across the globe: ⁠⁠https://www.cureleukaemia.co.uk/⁠ [⁠⁠https://www.cureleukaemia.co.uk/⁠]

"No Way I'm Done, I'm Not Going".

In this episode, we’re joined by Jenna Ostrowski, who was diagnosed with Acute Myeloid Leukaemia (AML) at 33 years old — after a visit to the dentist for persistent bleeding gums following a holiday.What’s in this episode: * The early symptoms Jenna experienced and why they were initially overlooked * The pivotal dentist visit that led to her diagnosis * Receiving a life-changing AML diagnosis and breaking the news to loved ones * Her experience being treated with Mylotarg and the impact of research-led care * Spending seven months in hospital and the mental challenges of isolation * Reaching remission and rebuilding life after treatment * Taking on the London to Paris cycle ride just months after recovery * Life today, including marriage, motherhood, and more... Thank you to HCR Law [https://www.hcrlaw.com/]for kindly sponsoring this epsiode. Find out more about Cure Leukaemia and how you can get involved and support blood cancer patients across the globe: ⁠⁠https://www.cureleukaemia.co.uk/⁠ [⁠⁠https://www.cureleukaemia.co.uk/⁠]